8 Recruiting Studies Using Secukinumab
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Secukinumab
A Study of Secukinumab to Evaluate Maintenance of Response in Participants With Non-radiographic Axial Spondyloarthritis Who Achieved Remission
📍 Novartis Investigative Site — Genk, Belgium
Non-radiographic Axial Spondyloarthritis
View Study & Checklist ➔Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR)
📍 Arizona Arthritis and Rheumatology Associates PLLC — Avondale, Arizona
Polymyalgia Rheumatica
View Study & Checklist ➔Utilization of a Microdevice for Psoriasis and Atopic Dermatitis
📍 University of California, San Francisco — San Francisco, California
Psoriasis
View Study & Checklist ➔A Pragmatic Trial of Interleukin-17 Inhibition Versus Janus Kinase Inhibition After Tumor Necrosis Factor-alpha Inhibitor Failure in Axial Spondyloarthritis
📍 The University of Texas health Science Center at Houston — Houston, Texas
Axial Spondyloarthritis (AxSpA)
View Study & Checklist ➔Secukinumab Open Label Roll-over Extension Protocol
📍 Providence Medical Foundation — Fullerton, California
Autoimmunity, Inflammation
View Study & Checklist ➔IL-17 Blockade to Decrease irAEs (REPLAY)
📍 Duke University Health System — Durham, North Carolina
Metastatic Melanoma
View Study & Checklist ➔Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA).
📍 Loma Linda University Health — Loma Linda, California
Juvenile Psoriatic Arthritis
View Study & Checklist ➔Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
📍 NYU Langone Health — New York, New York
Rheumatic Disease
View Study & Checklist ➔